Doctor profile · Federal record
Dr. Jameka McElroy-Brooklyn, PA-C
Physician Assistant · Arlington, VA
- NPI 1790155166
- 11 yrs on file
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2900 S Quincy St Ste 210
Arlington, VA 222069907
(703) 212-7546
Credentials & registration
- NPI registered
- September 2015 — 11 yrs on file
- Profile last updated
- January 10, 2024
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Illinois #085005649
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790155166. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
417
Distinct HCPCS
7
Medicare allowed
$20,673
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 160 | 42 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 70 | 69 | $80 | |
17000 |
Destruction of precancer skin growth, 1 growth | 65 | 65 | $45 | |
11102 |
Biopsy of related skin growth, first growth | 44 | 44 | $89 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 32 | 31 | $120 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 24 | 24 | $51 | |
17110 |
Destruction of skin growth, 1-14 growths | 22 | 22 | $102 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 108. This provider delivers 3.9× the peer median.Open Payments
Industry payments received
All-time total
$9,663
Transactions
111
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $1,670.51 | |
| LEO Pharma Inc. | 7 | $1,541.66 | |
| Eli Lilly and Company | 1 | $1,500.00 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $1,372.58 | |
| PFIZER INC. | 4 | $858.12 | |
| Incyte Corporation | 10 | $509.25 | |
| Janssen Biotech, Inc. | 18 | $474.03 | |
| Lilly USA, LLC | 12 | $454.20 | |
| ABBVIE INC. | 13 | $346.65 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $283.47 | |
| GENZYME CORPORATION | 8 | $213.36 | |
| UCB, Inc. | 5 | $121.18 | |
| Arcutis Biotherapeutics, Inc. | 5 | $111.30 | |
| Dermavant Sciences, Inc. | 4 | $83.01 | |
| Amgen Inc. | 2 | $52.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
115
Patients
74
Total drug cost
$4,638
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 39 | 20 | $1,864 |
| Ketoconazole | Generic | 29 | 17 | $765 |
| Triamcinolone Acetonide | Generic | 27 | 22 | $341 |
| Fluocinonide | Generic | 20 | 15 | $1,667 |
Frequently asked questions
What is Dr. Jameka McElroy-Brooklyn's medical specialty?
Dr. Jameka McElroy-Brooklyn practices Physician Assistant in Arlington, VA.
Where does Dr. Jameka McElroy-Brooklyn practice?
Dr. Jameka McElroy-Brooklyn practices at 2900 S Quincy St Ste 210, Arlington, VA 222069907. Office phone: 7032127546.
What is Dr. Jameka McElroy-Brooklyn's NPI?
Dr. Jameka McElroy-Brooklyn's National Provider Identifier (NPI) is 1790155166, issued by NPPES.
What procedures does Dr. Jameka McElroy-Brooklyn commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.